|
MechanismGPR38 antagonists |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Tranzyme Pharma, Inc.
0 Patents (Medical) associated with Tranzyme Pharma, Inc.
100 Deals associated with Tranzyme Pharma, Inc.
100 Translational Medicine associated with Tranzyme Pharma, Inc.